Scott Gerber
Concepts (359)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of publications
|
Most recent publication
|
Publications by all authors
|
Why?
|
|---|
Proteomics | 12 | 2004 | 36 |
Why?
| Cell Cycle Proteins | 9 | 2001 | 71 |
Why?
| Mass Spectrometry | 16 | 1999 | 57 |
Why?
| Proto-Oncogene Proteins | 2 | 2011 | 113 |
Why?
| Protein-Serine-Threonine Kinases | 2 | 2011 | 105 |
Why?
| Phosphorylation | 13 | 2001 | 224 |
Why?
| Endothelial Cells | 4 | 2008 | 80 |
Why?
| Endopeptidases | 3 | 2001 | 46 |
Why?
| Proteome | 4 | 2005 | 25 |
Why?
| Interferon-gamma | 5 | 2003 | 133 |
Why?
| Melanoma, Experimental | 5 | 2003 | 13 |
Why?
| Protein Processing, Post-Translational | 3 | 2004 | 78 |
Why?
| Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2008 | 25 |
Why?
| Interferon-alpha | 2 | 2008 | 43 |
Why?
| Mitosis | 1 | 2011 | 68 |
Why?
| Software | 3 | 2006 | 92 |
Why?
| Interleukin-12 | 3 | 2003 | 27 |
Why?
| Transcription, Genetic | 3 | 2006 | 253 |
Why?
| STAT1 Transcription Factor | 1 | 2009 | 11 |
Why?
| Dioxygenases | 1 | 2009 | 5 |
Why?
| Proteins | 4 | 1999 | 192 |
Why?
| Omentum | 1 | 2006 | 12 |
Why?
| Antigen-Antibody Complex | 1 | 2006 | 34 |
Why?
| Peritoneal Neoplasms | 1 | 2006 | 24 |
Why?
| Cytokines | 2 | 2003 | 207 |
Why?
| Serine | 1 | 2007 | 62 |
Why?
| Phosphoproteins | 3 | 2001 | 86 |
Why?
| Heterochromatin | 4 | 2004 | 10 |
Why?
| Isotope Labeling | 6 | 1999 | 13 |
Why?
| Signal Transduction | 4 | 2007 | 313 |
Why?
| HeLa Cells | 6 | 2001 | 107 |
Why?
| Mucopolysaccharidosis III | 2 | 2001 | 1 |
Why?
| Lymphoid Tissue | 1 | 2005 | 34 |
Why?
| Mice | 19 | 2001 | 623 |
Why?
| Cell Hypoxia | 3 | 2006 | 31 |
Why?
| Schizosaccharomyces | 4 | 2004 | 11 |
Why?
| Schizosaccharomyces pombe Proteins | 4 | 2004 | 7 |
Why?
| Prostate | 1 | 2005 | 55 |
Why?
| Peptide Mapping | 4 | 2001 | 27 |
Why?
| Neovascularization, Pathologic | 1 | 2003 | 64 |
Why?
| Saccharomyces cerevisiae | 6 | 2003 | 67 |
Why?
| N-Acetylgalactosamine-4-Sulfatase | 1 | 2001 | 1 |
Why?
| Acetylgalactosamine | 1 | 2001 | 3 |
Why?
| RNA Interference | 3 | 2004 | 75 |
Why?
| Glucosamine | 1 | 2001 | 11 |
Why?
| Hydrolases | 1 | 2001 | 14 |
Why?
| Enterotoxins | 1 | 2001 | 15 |
Why?
| Enzymes | 1 | 2001 | 22 |
Why?
| CpG Islands | 1 | 2001 | 26 |
Why?
| Capsid Proteins | 1 | 2001 | 19 |
Why?
| Mice, Inbred BALB C | 5 | 2001 | 176 |
Why?
| Oncogene Proteins, Viral | 1 | 2001 | 29 |
Why?
| Saccharomyces cerevisiae Proteins | 5 | 2001 | 58 |
Why?
| Vaccines, Synthetic | 1 | 2001 | 30 |
Why?
| Bacterial Toxins | 1 | 2001 | 24 |
Why?
| Viral Vaccines | 1 | 2001 | 35 |
Why?
| Adipocytes | 2 | 2009 | 11 |
Why?
| Adjuvants, Immunologic | 1 | 2001 | 73 |
Why?
| Animals | 21 | 2001 | 1031 |
Why?
| Guanine Nucleotide Exchange Factors | 2 | 2009 | 14 |
Why?
| Histone Deacetylases | 4 | 2002 | 30 |
Why?
| Escherichia coli Proteins | 1 | 2001 | 40 |
Why?
| Papillomaviridae | 1 | 2001 | 37 |
Why?
| Silent Information Regulator Proteins, Saccharomyces cerevisiae | 3 | 2002 | 4 |
Why?
| Amino Acid Sequence | 8 | 1999 | 319 |
Why?
| Humans | 19 | 2001 | 1856 |
Why?
| Gene Silencing | 3 | 2002 | 32 |
Why?
| CDC2 Protein Kinase | 2 | 2001 | 6 |
Why?
| Escherichia coli | 1 | 2001 | 143 |
Why?
| Vascular Endothelial Growth Factor Receptor-3 | 2 | 2003 | 9 |
Why?
| Cells, Cultured | 4 | 2001 | 447 |
Why?
| Insulin | 2 | 2009 | 129 |
Why?
| Chromatography, Liquid | 5 | 1999 | 33 |
Why?
| Spleen | 3 | 2005 | 129 |
Why?
| Tandem Mass Spectrometry | 3 | 2007 | 17 |
Why?
| Molecular Sequence Data | 6 | 2003 | 404 |
Why?
| Sirtuins | 3 | 2002 | 7 |
Why?
| Protein Kinases | 2 | 2003 | 64 |
Why?
| Cell Line, Tumor | 5 | 2005 | 208 |
Why?
| Multiprotein Complexes | 3 | 2006 | 11 |
Why?
| Fungal Proteins | 2 | 2002 | 45 |
Why?
| Glucose Transporter Type 4 | 2 | 2009 | 1 |
Why?
| Lymphocytes, Tumor-Infiltrating | 4 | 2003 | 20 |
Why?
| Spectrometry, Mass, Electrospray Ionization | 3 | 2001 | 9 |
Why?
| Centromere | 4 | 2004 | 9 |
Why?
| Carbon Isotopes | 2 | 2006 | 36 |
Why?
| Amino Acid Motifs | 2 | 2007 | 52 |
Why?
| Gene Expression Regulation, Fungal | 4 | 2002 | 23 |
Why?
| Cyclin B | 2 | 2001 | 4 |
Why?
| Algorithms | 4 | 2006 | 226 |
Why?
| Peptides | 4 | 2005 | 154 |
Why?
| Liver | 2 | 2007 | 248 |
Why?
| Mice, Transgenic | 5 | 2003 | 209 |
Why?
| Imidazoles | 2 | 2008 | 47 |
Why?
| Ubiquitin-Protein Ligases | 2 | 2007 | 41 |
Why?
| Repressor Proteins | 3 | 2005 | 96 |
Why?
| TOR Serine-Threonine Kinases | 1 | 2011 | 21 |
Why?
| Mice, Inbred C57BL | 5 | 2005 | 318 |
Why?
| Oleanolic Acid | 1 | 2011 | 13 |
Why?
| rab GTP-Binding Proteins | 1 | 2011 | 6 |
Why?
| Nitrogen Isotopes | 1 | 2011 | 4 |
Why?
| Deuterium | 1 | 2011 | 12 |
Why?
| Chromatography, Affinity | 2 | 2001 | 49 |
Why?
| Chromosomal Proteins, Non-Histone | 2 | 2001 | 6 |
Why?
| Phenotype | 2 | 2001 | 303 |
Why?
| Databases, Protein | 1 | 2010 | 8 |
Why?
| Vascular Endothelial Growth Factor A | 3 | 2003 | 94 |
Why?
| TRPC Cation Channels | 1 | 2010 | 4 |
Why?
| Proto-Oncogene Proteins c-myc | 1 | 2010 | 29 |
Why?
| Hepacivirus | 1 | 2010 | 15 |
Why?
| Cell Transplantation | 1 | 2010 | 20 |
Why?
| Hepatitis C | 1 | 2010 | 18 |
Why?
| Lymph Nodes | 3 | 2005 | 106 |
Why?
| Janus Kinases | 1 | 2009 | 2 |
Why?
| Growth Inhibitors | 1 | 2010 | 33 |
Why?
| Amino Acids, Dicarboxylic | 1 | 2009 | 5 |
Why?
| Neurospora crassa | 1 | 2009 | 1 |
Why?
| Hepatocytes | 1 | 2010 | 42 |
Why?
| Deferoxamine | 1 | 2009 | 16 |
Why?
| Cell Polarity | 1 | 2009 | 24 |
Why?
| Genes, Immediate-Early | 1 | 2009 | 10 |
Why?
| Sirtuin 2 | 3 | 2002 | 3 |
Why?
| Biological Clocks | 1 | 2009 | 13 |
Why?
| Lymphocyte Subsets | 1 | 2009 | 26 |
Why?
| Immunophenotyping | 2 | 2005 | 66 |
Why?
| Enzyme Induction | 1 | 2009 | 64 |
Why?
| Fetal Blood | 1 | 2009 | 54 |
Why?
| Neoplasm Metastasis | 2 | 2006 | 112 |
Why?
| Janus Kinase 1 | 1 | 2008 | 3 |
Why?
| TYK2 Kinase | 1 | 2008 | 2 |
Why?
| DEAD-box RNA Helicases | 1 | 2008 | 12 |
Why?
| Interferon-Stimulated Gene Factor 3, gamma Subunit | 1 | 2008 | 4 |
Why?
| Endoribonucleases | 1 | 2008 | 15 |
Why?
| Circadian Rhythm | 1 | 2009 | 50 |
Why?
| DNA-Binding Proteins | 2 | 2010 | 204 |
Why?
| Microfilament Proteins | 1 | 2009 | 41 |
Why?
| Hypoglycemic Agents | 1 | 2009 | 44 |
Why?
| Endoplasmic Reticulum | 1 | 2009 | 59 |
Why?
| Cell Division | 3 | 2003 | 273 |
Why?
| Microscopy, Fluorescence | 2 | 2005 | 137 |
Why?
| Cell Line | 2 | 2005 | 375 |
Why?
| T-Lymphocytes, Cytotoxic | 2 | 2005 | 52 |
Why?
| Ubiquitination | 1 | 2007 | 10 |
Why?
| Ubiquitin-Conjugating Enzymes | 1 | 2007 | 6 |
Why?
| Gamma Rays | 1 | 2008 | 38 |
Why?
| MicroRNAs | 1 | 2008 | 16 |
Why?
| Liver Extracts | 1 | 2007 | 2 |
Why?
| Neovascularization, Physiologic | 1 | 2008 | 68 |
Why?
| Cell Proliferation | 2 | 2005 | 227 |
Why?
| Time Factors | 3 | 2005 | 896 |
Why?
| Peritoneal Cavity | 1 | 2006 | 28 |
Why?
| Hematopoietic Stem Cells | 1 | 2009 | 69 |
Why?
| Green Fluorescent Proteins | 2 | 2003 | 105 |
Why?
| Gene Expression Regulation | 2 | 2008 | 277 |
Why?
| Vascular Cell Adhesion Molecule-1 | 1 | 2006 | 27 |
Why?
| Enzyme Inhibitors | 1 | 2009 | 216 |
Why?
| Models, Immunological | 1 | 2006 | 40 |
Why?
| Cell Movement | 2 | 2005 | 163 |
Why?
| Globins | 1 | 2006 | 21 |
Why?
| Epithelium | 1 | 2006 | 101 |
Why?
| Recombinant Proteins | 3 | 2003 | 290 |
Why?
| Cell Cycle | 1 | 2007 | 121 |
Why?
| Endothelial Growth Factors | 2 | 2003 | 47 |
Why?
| Disease Models, Animal | 1 | 2010 | 349 |
Why?
| Chromatin Assembly and Disassembly | 1 | 2006 | 6 |
Why?
| Peyer's Patches | 1 | 2005 | 7 |
Why?
| Specific Pathogen-Free Organisms | 1 | 2005 | 26 |
Why?
| RNA-Induced Silencing Complex | 1 | 2004 | 1 |
Why?
| Neoplasm Proteins | 1 | 2007 | 110 |
Why?
| Carrier Proteins | 1 | 2009 | 177 |
Why?
| Mutagenesis, Site-Directed | 2 | 2001 | 126 |
Why?
| Ribosomal Protein S6 Kinases, 90-kDa | 1 | 2005 | 6 |
Why?
| Small Ubiquitin-Related Modifier Proteins | 1 | 2004 | 6 |
Why?
| RNA, Messenger | 2 | 2008 | 394 |
Why?
| Substrate Specificity | 2 | 2001 | 90 |
Why?
| Antigens, Neoplasm | 1 | 2005 | 56 |
Why?
| Protein Binding | 4 | 2004 | 256 |
Why?
| Binding Sites | 2 | 2003 | 213 |
Why?
| Adenosine Triphosphatases | 1 | 2004 | 43 |
Why?
| MAP Kinase Signaling System | 1 | 2005 | 56 |
Why?
| Tumor Suppressor Proteins | 1 | 2005 | 51 |
Why?
| Macrophages | 1 | 2006 | 148 |
Why?
| Guanine Nucleotides | 1 | 2003 | 13 |
Why?
| Vascular Endothelial Growth Factor D | 1 | 2003 | 6 |
Why?
| Myoglobin | 1 | 2003 | 10 |
Why?
| GTP Phosphohydrolases | 1 | 2003 | 21 |
Why?
| Horses | 1 | 2003 | 18 |
Why?
| Sarcoma, Experimental | 1 | 2003 | 21 |
Why?
| Vascular Endothelial Growth Factor C | 1 | 2003 | 13 |
Why?
| Lymphocyte Activation | 1 | 2005 | 137 |
Why?
| Neoplasms | 1 | 2010 | 239 |
Why?
| Luminescent Proteins | 1 | 2003 | 67 |
Why?
| Flow Cytometry | 1 | 2005 | 216 |
Why?
| Yeasts | 1 | 2002 | 24 |
Why?
| Chromatids | 1 | 2001 | 2 |
Why?
| Metaphase | 1 | 2001 | 11 |
Why?
| Ribonuclease III | 3 | 2004 | 5 |
Why?
| Mammary Neoplasms, Experimental | 1 | 2003 | 37 |
Why?
| Mucopolysaccharidosis VI | 1 | 2001 | 1 |
Why?
| Plasmids | 3 | 2003 | 122 |
Why?
| Reference Standards | 1 | 2001 | 35 |
Why?
| Mice, Knockout | 3 | 2008 | 265 |
Why?
| Chromatin | 1 | 2002 | 29 |
Why?
| Immunohistochemistry | 1 | 2005 | 355 |
Why?
| Antibody Specificity | 1 | 2001 | 71 |
Why?
| T-Lymphocytes | 1 | 2005 | 182 |
Why?
| Vagina | 1 | 2001 | 30 |
Why?
| Virion | 1 | 2001 | 24 |
Why?
| 3T3-L1 Cells | 2 | 2009 | 6 |
Why?
| B-Lymphocytes | 1 | 2005 | 134 |
Why?
| Administration, Oral | 1 | 2001 | 170 |
Why?
| RNA, Fungal | 3 | 2004 | 26 |
Why?
| Affinity Labels | 1 | 1999 | 17 |
Why?
| Prostatic Neoplasms | 1 | 2006 | 120 |
Why?
| Transfection | 1 | 2003 | 237 |
Why?
| Histones | 3 | 2002 | 42 |
Why?
| Mice, SCID | 2 | 2009 | 61 |
Why?
| Enzyme Activation | 1 | 2001 | 177 |
Why?
| Immunoglobulin G | 1 | 2001 | 191 |
Why?
| Skin | 1 | 2001 | 177 |
Why?
| Trans-Activators | 1 | 2002 | 113 |
Why?
| Antibodies, Viral | 1 | 2001 | 104 |
Why?
| Guanosine Triphosphate | 2 | 2003 | 22 |
Why?
| Fourier Analysis | 2 | 2006 | 23 |
Why?
| Electrophoresis, Polyacrylamide Gel | 2 | 2007 | 167 |
Why?
| Fibroblasts | 1 | 2001 | 179 |
Why?
| Mice, Nude | 2 | 2003 | 72 |
Why?
| Genes, Reporter | 2 | 2004 | 111 |
Why?
| Trypsin | 2 | 2005 | 63 |
Why?
| Acetylation | 2 | 2002 | 46 |
Why?
| Reproducibility of Results | 2 | 2006 | 391 |
Why?
| Chromosomes, Fungal | 2 | 2004 | 15 |
Why?
| Models, Genetic | 2 | 2004 | 90 |
Why?
| RNA, Small Interfering | 2 | 2004 | 116 |
Why?
| Male | 3 | 2005 | 1553 |
Why?
| Endothelium, Vascular | 2 | 2003 | 139 |
Why?
| Biotinylation | 1 | 2011 | 7 |
Why?
| HEK293 Cells | 1 | 2011 | 16 |
Why?
| Models, Biological | 2 | 2006 | 410 |
Why?
| Nuclear Proteins | 2 | 2001 | 139 |
Why?
| Cullin Proteins | 1 | 2010 | 2 |
Why?
| Protein Stability | 1 | 2010 | 11 |
Why?
| Computational Biology | 1 | 2011 | 39 |
Why?
| Protein Transport | 1 | 2011 | 101 |
Why?
| Gels | 1 | 2010 | 35 |
Why?
| Mutation | 2 | 2004 | 340 |
Why?
| Biological Transport | 1 | 2011 | 129 |
Why?
| Transplantation, Heterologous | 1 | 2010 | 57 |
Why?
| Coculture Techniques | 1 | 2010 | 59 |
Why?
| Umbilical Veins | 1 | 2010 | 46 |
Why?
| Fluorescent Antibody Technique, Direct | 1 | 2009 | 8 |
Why?
| Carbocyanines | 1 | 2009 | 13 |
Why?
| Hemagglutinins | 1 | 2009 | 12 |
Why?
| Sequence Deletion | 1 | 2010 | 88 |
Why?
| Culture Media, Serum-Free | 1 | 2009 | 32 |
Why?
| Hemocyanin | 1 | 2009 | 16 |
Why?
| Prenylation | 1 | 2009 | 1 |
Why?
| Hematopoietic Stem Cell Mobilization | 1 | 2009 | 12 |
Why?
| Mice, Inbred NOD | 1 | 2009 | 24 |
Why?
| Protein Interaction Mapping | 1 | 2009 | 19 |
Why?
| Immunoglobulins | 1 | 2009 | 54 |
Why?
| Hypersensitivity, Delayed | 1 | 2009 | 35 |
Why?
| 3T3 Cells | 1 | 2009 | 54 |
Why?
| Electroporation | 1 | 2009 | 7 |
Why?
| Granulocyte Colony-Stimulating Factor | 1 | 2009 | 34 |
Why?
| Influenza A Virus, H5N1 Subtype | 1 | 2009 | 14 |
Why?
| RNA Polymerase II | 1 | 2008 | 14 |
Why?
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2010 | 71 |
Why?
| Cyclotrons | 1 | 2008 | 2 |
Why?
| Isotopes | 1 | 2008 | 4 |
Why?
| Whole-Body Irradiation | 1 | 2009 | 43 |
Why?
| Radiation Dosage | 1 | 2009 | 65 |
Why?
| Down-Regulation | 1 | 2010 | 150 |
Why?
| Cell Communication | 1 | 2010 | 72 |
Why?
| Glucose | 1 | 2011 | 120 |
Why?
| Exocytosis | 1 | 2009 | 15 |
Why?
| Jurkat Cells | 1 | 2008 | 26 |
Why?
| Epitopes | 1 | 2009 | 86 |
Why?
| Fibronectins | 1 | 2010 | 57 |
Why?
| Thymus Gland | 1 | 2009 | 57 |
Why?
| Complex Mixtures | 1 | 2008 | 8 |
Why?
| Lysine | 1 | 2008 | 47 |
Why?
| Chromosome Mapping | 1 | 2009 | 107 |
Why?
| Collagen | 1 | 2010 | 118 |
Why?
| Fluorescent Dyes | 1 | 2009 | 115 |
Why?
| Structural Homology, Protein | 1 | 2007 | 1 |
Why?
| Cell Survival | 1 | 2010 | 229 |
Why?
| G2 Phase | 1 | 2007 | 20 |
Why?
| Actins | 1 | 2009 | 112 |
Why?
| Protein Kinase Inhibitors | 1 | 2008 | 59 |
Why?
| G1 Phase | 1 | 2007 | 27 |
Why?
| Phosphopeptides | 1 | 2007 | 7 |
Why?
| Histocompatibility Antigens Class I | 1 | 2008 | 32 |
Why?
| Pheromones | 1 | 2007 | 3 |
Why?
| Hematopoietic Stem Cell Transplantation | 1 | 2009 | 49 |
Why?
| Structure-Activity Relationship | 1 | 2008 | 124 |
Why?
| Chromatography | 1 | 2007 | 33 |
Why?
| Recombinant Fusion Proteins | 1 | 2009 | 189 |
Why?
| Protein Structure, Tertiary | 1 | 2009 | 163 |
Why?
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2007 | 48 |
Why?
| Nocodazole | 1 | 2006 | 9 |
Why?
| Blotting, Western | 1 | 2009 | 275 |
Why?
| Animals, Newborn | 1 | 2008 | 175 |
Why?
| Eye Proteins | 1 | 2006 | 26 |
Why?
| Calibration | 1 | 2006 | 37 |
Why?
| Quality Control | 1 | 2006 | 54 |
Why?
| Erythropoiesis | 1 | 2006 | 25 |
Why?
| Up-Regulation | 1 | 2008 | 183 |
Why?
| Gene Deletion | 1 | 2006 | 121 |
Why?
| Mice, Inbred A | 1 | 2005 | 15 |
Why?
| Arginine | 1 | 2006 | 57 |
Why?
| Cytotoxicity Tests, Immunologic | 1 | 2005 | 23 |
Why?
| Antigens, CD45 | 1 | 2005 | 30 |
Why?
| Lymphocyte Count | 1 | 2005 | 38 |
Why?
| Ovalbumin | 1 | 2005 | 32 |
Why?
| Probability | 1 | 2006 | 190 |
Why?
| Phosphorus Isotopes | 1 | 2005 | 9 |
Why?
| Tuberous Sclerosis | 1 | 2005 | 6 |
Why?
| Phorbol Esters | 1 | 2005 | 12 |
Why?
| Cost-Benefit Analysis | 1 | 2006 | 118 |
Why?
| Genes, Fungal | 1 | 2006 | 36 |
Why?
| Ions | 1 | 2005 | 29 |
Why?
| RNA Helicases | 1 | 2004 | 8 |
Why?
| Methyltransferases | 1 | 2004 | 18 |
Why?
| Dose-Response Relationship, Radiation | 1 | 2005 | 85 |
Why?
| Antigen Presentation | 1 | 2005 | 28 |
Why?
| Niacinamide | 1 | 2004 | 8 |
Why?
| RNA, Untranslated | 1 | 2004 | 15 |
Why?
| Ubiquitin | 1 | 2005 | 41 |
Why?
| Image Processing, Computer-Assisted | 1 | 2006 | 138 |
Why?
| Argonaute Proteins | 1 | 2004 | 2 |
Why?
| Epidermal Growth Factor | 1 | 2005 | 51 |
Why?
| Guanosine Diphosphate | 1 | 2003 | 9 |
Why?
| Macromolecular Substances | 1 | 2004 | 92 |
Why?
| Chemokine CXCL10 | 1 | 2003 | 22 |
Why?
| Precipitin Tests | 1 | 2004 | 81 |
Why?
| Vascular Endothelial Growth Factors | 1 | 2003 | 39 |
Why?
| Nucleosomes | 1 | 2004 | 7 |
Why?
| Promoter Regions, Genetic | 1 | 2006 | 188 |
Why?
| Tumor Cells, Cultured | 1 | 2006 | 233 |
Why?
| Mice, Inbred C3H | 1 | 2003 | 86 |
Why?
| Protein Kinase C | 1 | 2005 | 93 |
Why?
| Cell Death | 1 | 2003 | 94 |
Why?
| Lymphokines | 1 | 2003 | 61 |
Why?
| Killer Cells, Natural | 1 | 2003 | 62 |
Why?
| Intercellular Signaling Peptides and Proteins | 1 | 2003 | 64 |
Why?
| Anoxia | 1 | 2003 | 85 |
Why?
| DNA, Ribosomal | 1 | 2002 | 10 |
Why?
| Female | 1 | 2001 | 1643 |
Why?
| Cyclin B1 | 1 | 2001 | 1 |
Why?
| Anaphase | 1 | 2001 | 4 |
Why?
| RNA-Binding Proteins | 1 | 2004 | 55 |
Why?
| Rats | 1 | 2010 | 530 |
Why?
| Apoptosis | 1 | 2008 | 265 |
Why?
| Sensitivity and Specificity | 1 | 2005 | 427 |
Why?
| Cell Nucleus | 1 | 2004 | 169 |
Why?
| Xenopus laevis | 1 | 2001 | 49 |
Why?
| Oocytes | 1 | 2001 | 45 |
Why?
| Oxygen | 1 | 2003 | 179 |
Why?
|
|
Gerber's Networks
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|
